Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07356323 · ClinicalTrials.gov registry record · NA
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
A NA study of Arthroplasty, Replacement, Knee and Arthroplasty Total Hip Replacement, sponsored by Solventum US.
- Recruiting
- Registry status
- NA
- Development phase
- 179
- Enrollment target
- 2
- Study locations
NCT07356323 is a NA study of Arthroplasty, Replacement, Knee and Arthroplasty Total Hip Replacement that is actively recruiting participants, run by Solventum US. The registered enrollment target is 179 participants, roughly in line with the 188-participant average among 12 other Arthroplasty, Replacement, Knee trials with a reported enrollment target. The trial reports 2 study locations across 2 states.
The verdict
NCT07356323, a NA study of Arthroplasty, Replacement, Knee and Arthroplasty Total Hip Replacement, is actively recruiting participants, sponsored by Solventum US.
- RECRUITING
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical study is to generate data on the intended use of a chlorhexidine gluconate (CHG)-impregnated antimicrobial incise drape. The study includes subjects undergoing primary hip or knee arthroplasty procedures. The study evaluates the intraoperative performance and safety of the incise drape during surgery, including assessment of contamination and operative characteristics. Participants will have a CHG-impregnated antimicrobial incise drape applied during their surgical procedure. During surgery, samples will be collected from the operative site to assess potential bacterial contamination.
Conditions Studied
Interventions
- DEVICE 3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG)
Study Locations (2)
Indiana
- Indiana University Health (IU Health) - Fishers
Utah
- University of Utah Health - Department of Orthopedics - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2026-02-19 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07356323
The ClinicalTrials.gov registry entry for NCT07356323 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 188-participant average among 12 other Arthroplasty, Replacement, Knee trials with a reported enrollment target. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Arthroplasty, Replacement, Knee appearing as the primary indexed condition, and to 1 intervention - of which 3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG) is the first listed.
NCT07356323 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Utah.
Frequently Asked Questions
What is clinical trial NCT07356323 about?
NCT07356323 is a clinical study titled "A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery". The goal of this clinical study is to generate data on the intended use of a chlorhexidine gluconate (CHG)-impregnated antimicrobial incise drape. The study includes subjects undergoing primary hip or knee arthroplasty procedures. The study evaluates the intraoperative performance and safety of the...
What is the current status of trial NCT07356323?
This trial is currently recruiting. It is a NA study. The enrollment target is 179 participants. The study started on 2026-02-19. Estimated completion is 2026-05.
What conditions does trial NCT07356323 study?
This clinical trial studies the following conditions: Arthroplasty, Replacement, Knee, Arthroplasty Total Hip Replacement.
What interventions are being tested in trial NCT07356323?
The interventions under investigation include: 3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG) (DEVICE).
Who is sponsoring clinical trial NCT07356323?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07356323 being conducted?
This trial has 2 study locations across Indiana, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthroplasty, Replacement, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real-component Vs All-cement Articulating Spacers for Periprosthetic Knee Infection
RECRUITING · NA
-
TracPatch in Total Knee Arthroplasty
ACTIVE NOT RECRUITING · NA
-
Music Therapy Versus Control for Total Knee Arthroplasty
COMPLETED · NA
-
Traditional vs Oral Fluid Management in Total Knee Arthroplasty
COMPLETED · NA
-
X-3 Polyethylene Survival Outcomes Study
COMPLETED · NA
-
Study to Evaluate ACB Versus FNB Early Postoperative Period Functional Outcomes After TKA
COMPLETED · NA
Explore more on PlainTrial
Arthroplasty, Replacement, Knee
All registered trials for this condition
Arthroplasty Total Hip Replacement
All registered trials for this condition
Indiana
All trials with a study site in Indiana
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.